Tenor Capital Management’s Psyence Biomedical Warrant PBMWW Stock Holding History

Tenor Capital Management’s Portfolio PBMWW Stock Details PBMWW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$3.65K	Hold	150,000	–	–	﹤0.01%	520
2026 Q1	$2.73K	Hold	150,000	–	–	﹤0.01%	481
2025 Q4	$2.77K	Hold	150,000	–	–	﹤0.01%	414
2025 Q3	$3.78K	Hold	150,000	–	–	﹤0.01%	371
2025 Q2	$3.04K	Hold	150,000	–	–	﹤0.01%	335
2025 Q1	$2.54K	Hold	150,000	–	–	﹤0.01%	282
2024 Q4	$2.16K	Hold	150,000	–	–	﹤0.01%	271
2024 Q3	$1.89K	Hold	150,000	–	–	﹤0.01%	260
2024 Q2	$1.57K	Hold	150,000	–	–	﹤0.01%	287
2024 Q1	$10.5K	Buy	+150,000	New	+$9.35K	﹤0.01%	243

Other funds holding PBMWW

HCI

Harraden Circle Investments New York $784M AUM 20.59% 1-Year Est. Return

PAMP

Polar Asset Management Partners Toronto, Ontario, Canada $6.07B AUM 34.81% 1-Year Est. Return

MMCAP International Grand Cayman, Cayman Islands $1.18B AUM 50.44% 1-Year Est. Return

Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $86.4B AUM 59.51% 1-Year Est. Return

Calamos Advisors Naperville, Illinois $30.1B AUM 30.03% 1-Year Est. Return

SCM

Saba Capital Management New York $3.9B AUM 12.9% 1-Year Est. Return

Clear Street New York $39.5B AUM 124.03% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

LMR Partners London, United Kingdom $26.8B AUM 68.38% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Tenor Capital Management's PBMWW Position: Q2 2026 in Review

Tenor Capital Management held its Psyence Biomedical Warrant (PBMWW) position steady in Q2 2026 at 150,000 shares worth $3.65K. The position accounts for ﹤0.01% of the portfolio, ranked #520.

Tenor Capital Management first reported a position in PBMWW in Q1 2024 and has held it in 10 quarters since. The position peaked at $10.5K in Q1 2024. 18 funds tracked by Wall St. Rank hold PBMWW as of Q2 2026.

Tenor Capital Management held 150,000 shares of Psyence Biomedical Warrant worth $3.65K as of Q2 2026.
Tenor Capital Management left its Psyence Biomedical Warrant share count unchanged in Q2 2026.
Psyence Biomedical Warrant made up ﹤0.01% of Tenor Capital Management's portfolio in Q2 2026, its #520 holding.
Tenor Capital Management first reported a position in Psyence Biomedical Warrant in Q1 2024 and has held it in 10 quarters since.
Tenor Capital Management's Psyence Biomedical Warrant position peaked at $10.5K in Q1 2024.
18 funds tracked by Wall St. Rank held Psyence Biomedical Warrant as of Q2 2026.

Based on Tenor Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.